Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Eli Lilly and Company(LLY) | 23,682 | 53,916 | +30,234 | $19.56M | $42.03M | 8.81% | +$22.47M |
| BridgeBio Pharma, Inc.(BBIO) | 962,883 | 927,711 | -35,172 | $33.29M | $40.06M | 8.40% | +$6.77M |
| Soleno Therapeutics Inc | 160,962 | 409,944 | +248,982 | $11.50M | $34.35M | 7.20% | +$22.84M |
| Ascendis Pharma A/SADR(ASND) | 195,523 | 179,926 | -15,597 | $30.47M | $31.06M | 6.51% | +$581.0K |
| Intuitive Surgical, Inc.(ISRG) | 36,499 | 56,674 | +20,175 | $18.08M | $30.80M | 6.46% | +$12.72M |
| Edwards Lifesciences Corp | 435,588 | 390,932 | -44,656 | $31.57M | $30.57M | 6.41% | -$996.6K |
| Gilead Sciences, Inc.(GILD) | 0 | 226,875 | +226,875 | $0 | $25.15M | 5.27% | +$25.15M |
| Boston Scientific Corporation(BSX) | 0 | 229,046 | +229,046 | $0 | $24.60M | 5.16% | +$24.60M |
| Cytokinetics, Incorporated(CYTK) | 585,812 | 601,439 | +15,627 | $23.54M | $19.87M | 4.17% | -$3.67M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 1,733,701 | 2,104,512 | +370,811 | $21.30M | $19.71M | 4.13% | -$1.59M |
| Teva Pharmaceutical Industries LimitedADS(TEVA) | 0 | 1,170,372 | +1,170,372 | $0 | $19.62M | 4.11% | +$19.62M |
| Corcept Therapeutics Incorporated(CORT) | 0 | 239,125 | +239,125 | $0 | $17.55M | 3.68% | +$17.55M |
| Natera, Inc.(NTRA) | 0 | 97,297 | +97,297 | $0 | $16.44M | 3.45% | +$16.44M |
| Adaptive Biotechnologies Corporation(ADPT) | 611,639 | 1,396,445 | +784,806 | $4.54M | $16.27M | 3.41% | +$11.72M |
| Dianthus Therapeutics, Inc.(DNTH) | 763,471 | 746,527 | -16,944 | $13.85M | $13.91M | 2.92% | +$58.4K |
| Structure Therapeutics IncADS | 704,864 | 670,575 | -34,289 | $12.20M | $13.91M | 2.92% | +$1.71M |
| Adma Biologics Inc | 0 | 569,704 | +569,704 | $0 | $10.37M | 2.18% | +$10.37M |
| Halozyme Therapeutics, Inc.(HALO) | 0 | 191,529 | +191,529 | $0 | $9.96M | 2.09% | +$9.96M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 213,402 | +213,402 | $0 | $7.76M | 1.63% | +$7.76M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 114,616 | 162,596 | +47,980 | $4.48M | $7.67M | 1.61% | +$3.20M |
| Phathom Pharmaceuticals, Inc.(PHAT) | 0 | 672,290 | +672,290 | $0 | $6.45M | 1.35% | +$6.45M |
| uniQure N.V.SHS(QURE) | 830,325 | 417,443 | -412,882 | $8.80M | $5.82M | 1.22% | -$2.98M |
| GeneDx Holdings Corp.CL A(WGS) | 0 | 61,507 | +61,507 | $0 | $5.68M | 1.19% | +$5.68M |
| Protara Therapeutics, Inc.(TARA) | 1,088,691 | 1,626,370 | +537,679 | $4.64M | $4.93M | 1.03% | +$290.1K |
| Outset Medical, Inc.(OM) | 166,666 | 166,666 | 0 | $1.84M | $3.20M | 0.67% | +$1.36M |
| Septerna, Inc.(SEPN) | 1,024,245 | 294,360 | -729,885 | $5.93M | $3.11M | 0.65% | -$2.82M |
| Replimune Group, Inc.(REPL) | 355,640 | 330,337 | -25,303 | $3.47M | $3.07M | 0.64% | -$398.7K |
| Zenas BioPharma, Inc.(ZBIO) | 295,148 | 215,314 | -79,834 | $2.33M | $2.09M | 0.44% | -$245.3K |
| Vir Biotechnology, Inc.(VIR) | 611,608 | 388,303 | -223,305 | $3.96M | $1.96M | 0.41% | -$2.01M |
| Kyverna Therapeutics, Inc.(KYTX) | 586,909 | 586,909 | 0 | $1.13M | $1.80M | 0.38% | +$669.1K |
| Disc Medicine, Inc.(IRON) | 0 | 30,661 | +30,661 | $0 | $1.62M | 0.34% | +$1.62M |
| Fulcrum Therapeutics, Inc.(FULC) | 202,139 | 188,304 | -13,835 | $582.2K | $1.30M | 0.27% | +$713.4K |
| Bicara Therapeutics Inc | 0 | 97,800 | +97,800 | $0 | $908.6K | 0.19% | +$908.6K |
| Metagenomi Therapeutics, Inc.(MGX) | 528,993 | 528,993 | 0 | $719.4K | $782.9K | 0.16% | +$63.5K |
| Karyopharm Therapeutics Inc.(KPTI) | 155,622 | 146,013 | -9,609 | $582.0K | $629.3K | 0.13% | +$47.3K |
| Hyperfine, Inc.CL A(HYPR) | 760,035 | 760,035 | 0 | $544.4K | $546.9K | 0.11% | +$2.5K |
| Mersana Therapeutics Inc | 1,705,036 | 1,567,413 | -137,623 | $586.9K | $464.0K | 0.10% | -$122.9K |
| Atai Life Sciences NvSHS | 196,858 | 196,858 | 0 | $267.7K | $431.1K | 0.09% | +$163.4K |
| Fractyl Health, Inc.(GUTS) | 214,236 | 214,236 | 0 | $254.9K | $347.1K | 0.07% | +$92.1K |
| Faeth Therapeutics, Inc.(FTH) | 0 | 14,718 | +14,718 | $0 | $126.3K | 0.03% | +$126.3K |
| Becton, Dickinson and Company(BDX) | 203,965 | 0 | -203,965 | $46.72M | $0 | — | -$46.72M |
| Inspire Medical Systems, Inc.(INSP) | 85,877 | 0 | -85,877 | $13.68M | $0 | — | -$13.68M |
| Keros Therapeutics, Inc.(KROS) | 389,384 | 0 | -389,384 | $3.97M | $0 | — | -$3.97M |
| LivaNova PLCSHS(LIVN) | 381,648 | 0 | -381,648 | $14.99M | $0 | — | -$14.99M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 12,261 | 0 | -12,261 | $7.78M | $0 | — | -$7.78M |
| Faeth Therapeutics, Inc.(FTH) | 294,374 | 0 | -294,374 | $116.0K | $0 | — | -$116.0K |
| Springworks Therapeutics Inc | 758,533 | 0 | -758,533 | $33.47M | $0 | — | -$33.47M |
| Veracyte, Inc.(VCYT) | 762,225 | 0 | -762,225 | $22.60M | $0 | — | -$22.60M |